Global OTC/DTC Infectious Disease Diagnostics Market Research Report 2024 with Guides for Executives and Marketing Staff, & Investment Analysts and Management Consultants

News provided by

Mar 21, 2024, 13:45 ET

DUBLIN, March 21, 2024 /PRNewswire/ -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market Analysis, Executive Guides, Customization and COVID-19 Market Opportunity Analysis." report has been added to ResearchAndMarkets.com's offering.

Covid-19 Awakens the sleeping giant of at-home diagnostics. Over the Counter and Direct to Consumer diagnostics are set to help solve the pandemic problem. New technologies create rapid test solutions for the home market. Self-Sampling technology key.

Genetic DTC testing led the way. Now Infectious disease testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done. And the COVID-19 situation will lead the charge. This report explores the DTC outlook for different syndromes. Find out where the action is and learn about the players.

Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play.

The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report. The report includes five year market forecasts.

Key Topics Covered:

i. Market Guides
A. Situation Analysis and COVID-19 Market Analysis
B. Guide for Executives and Marketing Staff
C. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition
1.1 What is OTC and DTC Testing?
1.2 OTC/DTC Testing - the quiet revolution in diagnostics
1.3 Self vs. Send - who knew?
1.4 Market Definition
1.5 Methodology
1.6 U.S. Medical Market and Clinical Laboratory Testing - Perspective

2. The Infectious Diseases - Guide to the Pathogens
2.1 HIV - Human Immunodeficiency Virus (AIDS)
2.2 HBV - Hepatitis B
2.3 HCV - Hepatitis C
2.4 HPV - Human papillomavirus
2.5 Coronavirus
2.6 Influenza
2.7 CT/NG - Chlamydia/Gonorhea
2.8 UTI
2.9 GAS
2.10 RESP

3. Industry Overview
3.1 Industry Participants
3.1.1 IVD Supplier
3.1.2 Independent lab specialized/esoteric
3.1.3 Independent lab national/regional
3.1.4 Independent lab analytical
3.1.5 Public National/regional lab
3.1.6 Hospital lab
3.1.7 Physician lab
3.1.8 Pharmacies
3.1.9 Audit body
3.2 The Clinical Laboratory Market Segments1
3.2.1 Traditional Market Segmentation
3.2.2 Laboratory Focus and Segmentation
3.2.3 Segmenting the OTC/DTC Market
3.3 Industry Structure
3.3.1 Hospital Testing Share
3.3.2 Economies of Scale
3.3.2.1 Hospital vs. Central Lab
3.3.3 Physician Office Lab's
3.3.3.1 The Problem with POLS
3.3.4 Physicians and OCT/DTC
3.3.5 Pharmacies and OCT/DTC
3.3.5.1 The Diagnostic Plight of Pharmacies - Trying to do good
3.3.5.2 The Theranos Legacy

4. Market Trends
4.1 Factors Driving Growth
4.1.1 Privacy and Anonymity
4.1.2 The Internet Effect.
4.1.3 Rapid Result.
4.1.4 The Wellness Movement
4.1.5 The COVID-19 Impact.
4.2 Factors Limiting Growth
4.2.1 Trust Factor
4.2.2 Infectious Disease is Declining But..
4.2.3 Wellness Hurts
4.2.4 Economic Growth improves Living Standards
4.3 Diagnostic Technology Development1
4.3.1 The Multiplex Paradigm Shift
4.3.2 NAT vs. Lateral Flow
4.3.3 The Unusual Role of GPS
4.3.4 Self and Send Competition
4.3.5 The Relationship to DTC Genetic
4.3.6 The Relationship to TeleHealth
4.3.7 Sample Collection - Who Knew?

5. OTC/DTC Infectious Disease Testing Recent Developments

Recent Developments - Importance and How to Use This Section
Importance of These Developments
How to Use This Section
FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
Lucira Health Files for $115M IPO
Spectrum Solutions Gets CE Mark for Saliva Collection Devices
Sherlock Biosciences Receives Gates Foundation Grant for COVID-19 Self-Test
LabCorp Receives EUA for OTC COVID-19 Test Home Collection Kit
FemtoDx Launches Rapid At-Home Test Development for COVID-19
FDA approves first at-home coronavirus test
Free Home HIV Tests Detect More Infections
Biohacking trend supports self testing
PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market
Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test
OraSure Technologies, Inc. Announces Two Acquisitions
Nigerian Govt Approves Alere HIV Self-Test Kit
Boots launches UTI test and treat service across 37 branches
Scanwell Health moves beyond home UTI testing with a nationwide kidney disease study partnership
Healthy.io raises $18 million for at-home urinalysis tests
LetsGetChecked collects $30M more for at-home health testing
TestCard, a $4 Urine Test Read by Smartphone
Digital Health Startup EverlyWell Raises $50M
Thriva adds test-at-home kits for female hormone and cortisol stress
Tasso scores $6.1M for patch-based home blood testing
DBS Systems HEMAXIS receives CE/IVD mark
Abbott HbA1c point-of-care test reliably diagnoses diabetes

6. Profiles of Key Diagnostic Testing Companies

1DropDiagnostics
Abbott Diagnostics
Ador Diagnostics
Akonni Biosystems
Alveo Technologies
Applied BioCode
Atomo Diagnostics
Aus Diagnostics
Becton, Dickinson and Company
Binx Health
Biocartis
bioMerieux Diagnostics
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Cepheid (now Danaher)
Curetis N.V. / Curetis GmbH
DBS Systems
Diagenode Diagnostics
Diasorin S.p.A
Ellume
Everywell
Healthy.io
Hologic
Inflammatix
Invetech
Janssen Diagnostics
Karius
Laboratory Corporation of America
Letsgetchecked
Lexagene
Luminex Corp
Mbio Diagnostics
Mesa Biotech
Mobidiag
myLabBox
Mylan
Nanomix
Orasure
Oxford Nanopore Technologies
Panagene
Primerdesign
Prominex
Qiagen Gmbh
Lucira Health
Quantumdx
Quest Diagnostics
Quidel
Roche Molecular Diagnostics
Scanwell Health
Seegene
Seventh Sense Biosystems
Siemens Healthineers
T2 Biosystems
TestCard
Thermo Fisher Scientific Inc.
Thriva
XCR Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/dii5h3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets